Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis

Inflammation

Volumn 21, Issue 1, 1997, Pages 113-131

  Fuseler, John W ^a   Conner, Elaine M ^a   Davis, Jonathan M ^a   Wolf, Robert E ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; NITRATE; NITRIC OXIDE; NITRITE; PEPTIDOGLYCAN POLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BIOASSAY; BLOOD LEVEL; BONE EROSION; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HISTOPATHOLOGY; MACROPHAGE; MEDIATOR; MONOCYTE; NONHUMAN; OSTEOCLAST; PANNUS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RAT; SYNOVITIS; SYNOVIUM;

ACUTE DISEASE; ANIMALS; ARTHRITIS; CYTOKINES; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1; INTERLEUKIN-6; NITRIC OXIDE; PEPTIDOGLYCAN; RATS; RATS, INBRED LEW; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030911765     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027351111240     Document Type: Article

References (79)

1. CROMARTIE, W. J., J. C. CRADDOCK, J. H. SCHWAB, S. K. ANDERLE, and C. H. YANG. 1977. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J. Exp. Med. 146:1585-1602.
2. CLARK, R. L., J. T. CUTTINO, JR., S. K. ANDERLE, W. J. CROMARTIE, and J. H. SCHWAB. 1979. Radiological analysis of arthritis in rats after systemic injection of streptococcal cell walls. Arthritis Rheum. 22: 25-35.
3. WILDER, R. L., J. B. ALLEN, L. M. WAHL, G. B. CALANDRA, and S. M. WAHL. 1983. The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat: comparative studies in arthritis-resistant and-susceptible inbred rat strains. Arthritis Rheum. 26:1442-1451.
4. ALLEN, J. B. and R. L. WILDER. 1985. Regulation of susceptibility to bacterial cell wall-induced arthritis in rats. Arthritis Rheum. 28:1318-1319.
5. WILDER, R. L., J. B. ALLEN, and C. HANSEN. 1987. Thymus-dependent and -independent regulation of la antigen expression in situ by cells in the synovium of rats with streptococcal cell wall-induced arthritis: differences in site and intensity of expression in euthymic, athymic, and cyclosporin A-treated LEW and F344 rats. J. Clin. Invest. 79:1160-1171.
6. ALLEN, J. B., D. G. MALONE, S. M. WAHL, G. B. CALANDRA, and R. L. WILDER. 1985. Role of the thymus in streptococcal cell wall-induced arthritis and granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats. J. Clin. Invest. 76:1042-1056.
7. DALLDORF, F. G., W. J. CROMARTIE, S. K. ANDERLE, R. L. CLARK, and J. H. SCHWAB. 1980. Relation of experimental arthritis to the distribution of streptococcal cell wall fragments. Am. J. Pathol. 100:383-391.
8. WILDER, R. L. 1988. Streptococcal cell wall-induced polyarthritis in rats. In: Handbook of Animal Models for the Rheumatic Diseases. Vol. 1. R. A. Greenwald and H. Diamond, Editors. Boca Raton, Florida. CRC Press., 33-44.
9. WAHL, S. M., J. B. ALLEN, K. OHURA, D. E. CHENOWETH, and A. R. HAND. 1991. IFN-γ inhibits inflammatory cell recruitment and the evolution of bacterial cell wall-induced arthritis. J. Immunol. 146:95-100.
10. ALLEN, J. B., C. L. MANTHEY, A. R. HAND, K. OHURA, L. ELLINGSWORTH, and S. M. WAHL. 1990. Rapid onset of synovial inflammation and hyperplasia induced by transforming growth factor b. J. Exp. Med. 171:231-247.
11. WAHL, S. M. 1994. Transforming growth factor b: The good, the bad and the ugly. J. Exp. Med. 180:1587-1590.
12. WAHL, S. M., J. B. ALLEN, K. L. HINES, T. IMAMICHI, A. M. WAHL, L. T. FURCHT, and J. B. MCCARTHY. 1994. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J. Clin. Invest. 94:655-662.
13. MCCARTNEY-FRANCIS, N., J. B. ALLEN, D. E. MIZEL, J. E. ALBINA, Q.-W. XIE, C. F. NATHAN, and S. M. WAHL. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:749-754.
14. IGNARRO, L. J. 1989. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Cir. Res. 65:1-21.
15. STUEHR, D. J. and C. F. NATHAN. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555.
16. LI, L., G. L. NICOLSON, and I. J. FIDLER. 1991. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res. 51:245-254.
17. GRISHAM, M. B., R. D. SPECIAN, and T. E. ZIMMERMAN. 1994. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J. Pharm. Exp. Therap. 271:1114-1124.
18. NUSSLER, A. K. and T. R. BILLIAR. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leak. Biol. 54:171-178.
19. DABBAGH, A. J., D. R. BLAKE, and C. J. MORRIS. 1992. Effect of iron complexes on adjuvant arthritis. Ann. Rheum. Dis. 51:516-521.
20. MISHELL, B. B. and S. M. SHIIGI, editors. 1980. Selected Methods in Cellular Immunology. W.H. Freeman and Co., New York. Pp22-23.
21. BRISTOL, L. A., S. K. DURUM, and S. P. EISENBURG. 1993. Differential regulation of group A streptococcal peptidoglycan-polysaccharide(PG/APS)-stimulated macrophage production of IL-1 by rat strains susceptible and resistant to PG/APS-induced arthritis. Cell. Immunol. 149:130-143.
22. RUFF, M. R. and G. E. GIFFORD. Tumor necrosis factor. In Lymphokines, Vol. 2. E. Pick, editor. Academic Press, New York. 235-273.
23. NAKAI, S., K. MIZUMO, M. KANETA, and H. YOSHIKATSU. 1988. A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line. Biochem. Biophys. Res. Comm. 154:1189-1196.
24. FREI, K., T. P. LEIST, A. MEAGER, P. GALLO, D. LEPPERT, R. M. ZINKERNAGEL, and A. FONTANA. 1988. Production of B cell stimulatory factor-2 and inferferon-g in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J. Exp. Med. 168:449-453.
25. MOSMANN, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:55-63.
26. GRISHAM, M. B., G. G. JOHNSON, M. D. GAUTREAUX, and R. D. BERG. 1995. Measurement of nitrate and nitrite in extracellular fluids: A window to systemic nitric oxide determination. Methods 7:84-90.
27. DUFF, G. W. 1994. Cytokines and acute phase proteins in rheumatoid arthritis. Scand. J. Rheumatol. 23(Suppl 100): 9-19.
28. WAHL, S. M., D. A. HUNT, J. B. ALLEN, R. L. WILDER, L. PAGLIA, and A. R. HAND. 1986. Bacterial cell wall-induced hepatic granulomas. A in vivo model of T cell dependent fibrosis. J. Exp. Med. 163:884-902.
29. AREND, W. P. and J. M. DAYER. 1990. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 33:305-315.
30. AKIRA, S., T. TAGA, and T. KISHIMOTO. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1-78.
31. STREITER, R. M., S. L. KUNKEL, H. J. SHOWELL, D. G. REMICK, S. H. PHAN, P. A. WARD, and R. M. MARKS. 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS and ILIβ. Science 243:1467-1469.
32. POBER, J. S., M. A. GIMBRONE, JR., L. A. LAPIERRE, D. L. MENDRICK, W. FRIES, R. ROTHLEIN, and T. A. SPRINGER. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon. J. Immunol. 137:1893-1896.
33. BEVILACQUA, M. P., J. S. POBER, M. E. WHELLER, R. S. COTRAN, and M. A. GIMBRONE JR. 1985. Interleukin-1 acts on cultured human vascular endothelium to increase the adherence of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J. Clin. Invest. 76:975-983
34. BRENNAN, F. M., R. N. MAINI, and M. FELDMANN. 1992. TNFa A pivotal role in rheumatoid arthritis? Brit. J. Rheum. 31:293-298.
35. YOCUM, D. E., L. ESPARZA, S. DUBRY, J. B. BENJAMIN, R. VOLZ, and P. SCUDERI. 1989. Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell Immunol. 122:131-145.
36. HOPKINS, S. J. and A. MEAGER. 1988. Cytokines in synovial fluid. II. The presence of tumor necrosis factor and interferon. Clin. Exp. Immunol. 73:88-92.
37. HUSBY, G. and R. C. WILLIAMS, JR. 1988. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J. Autoimmun. 1:363-371.
38. CHU, C. Q., M. FIELD, M. FELDMANN, and R. N. MAINI. 1991. Localization of tumor necrosis factor a in synovial tissue and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34:1125-1132.
39. DELEURAN, B. W., C.-Q. CHU, M. FIELD, F. M. BRENNAN, T. MITCHELL, M. FELDMANN, and R. N. MAINI. 1992. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor a. Arthritis Rheum. 35:1170-1178.
40. BRENNAN, F. M., D. CHANTRY, A. JACKSON, R. MAINI, and M. FELDMANN. 1989. Inhibitory effect of TNF a antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet II:244-247.
41. WILLIAMS, R. O., M. FELDMANN, and R. N. MAINI. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. U.S.A. 89:9784-9788.
42. PIQUET, P. F., G. E. GRAU, C. VESIN, H. LOETSCHER, R. GENTZ, and W. LESSLAUER. 1992. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumor necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77:510-514.
43. MAINI, R. N., F. M. BRENNAN, R. WILLIAMS, C. Q. CHU, A. P. COPE, D. GIBBONS, and M. ELLIOTT. 1993. TNF-α in rheumatoid arthritis and prospects of anti-TNF therapy. Clin. Exp. Rheum. 11(Suppl. 8)S173-S175.
44. M. J. ELLIOTT, R. N. MAINI, M. FELDMANN, A. LONG-FOX, P. CHARLES, P. KATSIKIS, F. M. BRENNAN, J. WALKER, H. BIJL, J. GHRAYEB, and J. N. WOODY. 1993. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis and Rheum. 36:1681-1690.
45. SYMONS, J. A., N. C. WOOD, F. S. DI GIOVINE, and G. W. DUFF. 1988. Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity, IL-1 and IL-1 inhibition. J. Immunol. 141:2612-2618.
46. EASTGATE, J. A., J. A. SYMONS, N. C. WOOD, S. J. CAPPER, and G. W. DUFF. 1991. Plasma levels of interleukin-1 alpha in rheumatoid arthritis. Br. J. Rheumatol. 30:295-297.
47. MAURY, C. P., L. C. ANDERSON, A. M. TEPPO, S. PARTANEN, and E. JU-VONEN. 1988. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin-1 beta concentrations in anaemic patients and of interleukin-1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann. Rheum. Dis. 47:972-978.
48. MIYASAKA, N., K. SATO, M. GOTO, M. SASANO, M. NATSUYAMA, K. INOUE, N. SASANO, M. NATSUYAMA, and K. NISHIOKA. 1988. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction. Arthritis Rheum. 31:480-486.
49. EASTGATE, J. A., J. A. SYMONS, N. C. WOOD, F. M. GRINLINTON, F. S. DI GIOVINE, and G. W. DUFF. 1988. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 2:706-709.
50. SHORE, A., S. JAGLAL, and E. C. KEYSTONE. 1986. Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to early events in the onset or exacerbation of rheumatoid arthritis. Clin. Exp. Immunol. 65:293-302.
51. VAN DEN BERG, W. B., L. A. B. JOOSTEN, M. HELSEN, and F. A. J. VAN DE LOO. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95:237-243.
52. VAN DE LOO, A. A. J., O. J. ARNTZ, A. C. BAKKER, P. L. E. M. VAN LENT, M. J. M. JACOBS, and W. B. VAN DEN BERG. 1995. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. Am. J. Path. 146:239-249.
53. MAKAROV, S. S., J. C. OLSEN, W. N. JOHNSON, S. K. ANDERLE, R. R. BROWN, A. S. BALDWIN, J. S. HASKILL, and J. H. SCHWAB. 1996. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc. Natl. Acad. Sci. U.S.A. 93:402-406.
54. ISSEKUTZ, A. C., A. MEAGER, I. OTTERNESS, and T. B. ISSEKUTZ. 1994. The role of tumor necrosis factor-alpha and IL-1 in polymorphonuclear leukocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin. Exp. Immunol. 97:26-32.
55. VAN DE LOO, F. A. J., L. A. B. JOOSTEN, P. L. E. M. VAN LENT, O. J. ARNTZ, and W. B. VAN DEN BERG. 1995. Role of interleukin-1 tumor necrosis factor α and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38:164-172.
56. PETTIPHER, E. R., G. A. HIGGS, and B. HENDERSON. 1986. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. U.S.A. 83:8749-8753.
57. MANOLIOS, N., C. GECZY, and L. SCHRIEBER. 1991. Lymphocyte migration in health and inflammatory rheumatic disease. Semin. Arthritis Rheum. 20:339-352.
58. POBER, J. S. and R. S. COTRAN. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:27-52.
59. OPPENHEIM, J. J., C. O. C. ZACHARIAE, N. MUKADIA, and K. MATSUSHIMA. 1991. Properties of the novel proinflammatory supergene "intercine" cytokine family. Ann. Rev. Immunol. 9:617-648.
60. KOCH, A. B., S. L. KUNKEL, L. A. HARLOW, B. JOHNSON, H. L. EVANOFF, G. K. HAINES, M. D. BURDICK, R. M. POPE, and R. M. STRIETER. 1992. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90:722-729.
61. WILDER, R., P. J. CASE, L. J. CROFFORD, G. K. KUMKUMIAN, R. LAFYATIS, E. F. REMMERS. H. SANO, E. M. STERNBERG, and D. E. YOCUM. 1991. Endothelial cells and the pathogenesis of rheumatoid arthritis in humans and streptococcal cell wall arthritis in Lewis rats. J. Cell Biochem. 45:162-166.
62. HAYASHIDA, K., T. OCHI, M. FUJIMOTO, H. OWAKI, Y. SHIMAOKA, K. ONO, and K. MATSU MOTO. 1992. Bone-marrow changes in adjuvant-induced and collagen-induced arthritis. Interleukin-1 and interleukin-6 activity and abnormal myelopoiesis. Arthritis Rheum. 35:241-245.
63. HOUSSIAU, F. A., J. P. DEVOGELAER, J. VAN DAMME, C. N. DE DEUXCHAISNES, and J. VAN SNICK. 1988. Inteleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31:784-788.
64. HIRANO, T., T. MATSUDA, M. TURNER, N. MIYASAKA, G. BUCHAN, B. TANG, K. SATO, M. SHIMIZU, R. MAINI, M. FELDMANN, and T. KISHIMOTO. 1988. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18:1791-1801.
65. MIYASAKA, N., K. SATO, M. GOTO, M. SASANO, M. NATSUYAMA, K. INOUE, and K. NISHIOKA. 1988. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: a possible involvement in joint destruction. Arthritis Rheum. 31:480-486.
66. MIYASAKA, N., K. SATO, J. HASHIMOTO, H. KOHSAKA, K. YAMAMOTO, M. GOTO, K. INOUE, T. MATSUDA, T. HIRANO, T. KISHIMOTO, and K. NISHIOKA. 1989. Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. Clin. Immunol. Immunopathol. 52:238-247.
67. JILKA, R. L., G. HANGOC, G. GIRASOLE, G. PASSERI, D. C. WILLIAMS, J. S. ABRAMS, B. BOYCE, H. BROXMEYER, and S. C. MANOLAGAS. 1992. Increased osteoclasts development after estrogen loss: Mediation by interleukin-6. Science 257:88-91.
68. GUERNE, P. A., B. L. ZURAW, J. H. VAUGHAN, D. A. CARSON, and M. LOTZ. 1989. Synovium as a source of interleukin-6 in vitro. J. Clin. Invest. 83:585-592.
69. ISHIMI, Y., C. MIYAURA, C. H. JIN, T. AKATSU, E. ABE, Y. NAKAMURA, A. YAMAGUCHI, S. YOSHIKI, T. MATSUDA, T. HIRANO, T. KISHIMOTO, and T. SUDA. 1990. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145:3297-3303.
70. FIRESTEIN, G. S. and N. J. ZVAIFLER. 1990. How important are T cells in chronic rheumatoid arthritis. Arthritis Rheum. 33:768-772.
71. FIRESTEIN, G. S. 1994. Rheumatoid arthritis and pannus. In: Klippel J.H., Dieppe P., eds. Rheumatology, London, Gower Publications, Mosby-Year Book, Europe Ltd. 3(12): 1-30.
72. DE LA MATA, J., H. L. UY, T. A. GUISE, B. STORY, B. F. BOYCE, G. R. MUNDY, and G. D. ROODMAN. 1995. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J. Clin. Invest. 95:2846-2852.
73. LOWIK, C. W. G. M., G. VAN DER PLUIJIM, H. BLYOYS, K. HOEKMAN, O. L. M. BIJVOET, L. A. AARDEN, and S. E. PAPAPOULOS. 1989. Parathyroid hormone(PTH) and PTH-like protein(PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem. Biophys. Res. Commun. 162:1546-1552.
74. FEYEN, J. H. M., P. ELFORD, F. E. DIPADOVA, and U. TRESHSEL. 1989. Interleukin-6 is produced by bone and modulated by parathyroid hormone. J. Bone Miner. Res. 4:633-638.
75. KURIHARA, H., D. BERTOLINI, T. SUDA, Y. AKIYAM, and G. D. ROODMAN. 1990. IL-6 stimulates osteoclasts-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J. Immunol. 144:4226-4230.
76. BLACK, K., I. R. GARRETT, and G. R. MUNDY. 1991. Chinese hamster cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology 128:2657-2659.
77. RALSTON, S. H., D. TODD, M. HELFRICH, N. BENJAMIN, and P. S. GRABOWSKI. 1994. Human osteoblasts-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135:330-336.
78. MARCINKIEWICZ, J., A. GRABOWSKA, and B. CHAIN. 1995. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25:947-951.
79. ZVAIFLER N. J. 1995. Macrophages and the synovial lining. Scand. J. Rheum. 24:67-75.